# A Study of GC203 TIL in Advanced Malignant Solid Tumors

> **NCT06375187** · PHASE1 · RECRUITING · sponsor: **Shanghai Juncell Therapeutics** · enrollment: 18 (estimated)

## Conditions studied

- Solid Tumor
- Gynecologic Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Lung Cancer

## Interventions

- **BIOLOGICAL:** Engineering Tumor Infiltrating Lymphocytes

## Key facts

- **NCT ID:** NCT06375187
- **Lead sponsor:** Shanghai Juncell Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-29
- **Primary completion:** 2026-11-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06375187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06375187, "A Study of GC203 TIL in Advanced Malignant Solid Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06375187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*